Extracellular vesicles in cardiovascular diseases: pathogenic mediators, diagnostic tools, and therapeutic vectors
Authors:
Open Access
- 8 October 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 12, 1666589
Abstract
Cardiovascular diseases (CVDs), the leading global cause of mortality, underscore an urgent need for innovative diagnostic and therapeutic strategies. Extracellular vesicles (EVs)—lipid-bilayer nanoparticles transporting bioactive cargo (microRNAs, proteins, lipids)—are critical mediators of intercellular communication in CVD pathogenesis. They exhibit functional duality: propagating pathology (inflammation, fibrosis, thrombosis) while facilitating tissue repair. This review synthesizes EV biogenesis mechanisms, isolation methodologies, source-specific functions, and multifaceted roles in atherosclerosis, myocardial infarction, heart failure, and stroke. We further evaluate EV-based diagnostic biomarkers, engineered therapeutic applications, clinical translation challenges, and future directions.Keywords
This publication has 202 references indexed in Scilit:
- Bacteria‐Derived Outer‐Membrane Vesicles Hitchhike Neutrophils to Enhance Ischemic Stroke TherapyAdvanced Materials, 2023
- A compendium of single extracellular vesicle flow cytometryJournal of Extracellular Vesicles, 2023
- Updating MISEV: Evolving the minimal requirements for studies of extracellular vesiclesJournal of Extracellular Vesicles, 2021
- Harnessing the Natural Healing Power of Colostrum: Bovine Milk‐Derived Extracellular Vesicles from Colostrum Facilitating the Transition from Inflammation to Tissue Regeneration for Accelerating Cutaneous Wound HealingAdvanced Healthcare Materials, 2021
- Biodistribution of extracellular vesicles following administration into animals: A systematic reviewJournal of Extracellular Vesicles, 2021
- Telocytes-Derived Extracellular Vesicles Alleviate Aortic Valve Calcification by Carrying miR-30bESC Heart Failure, 2021
- Extracellular vesicles from monocyte/platelet aggregates modulate human atherosclerotic plaque reactivityJournal of Extracellular Vesicles, 2021
- Myocardial ischemia‐reperfusion induced cardiac extracellular vesicles harbour proinflammatory features and aggravate heart injuryJournal of Extracellular Vesicles, 2021
- Casein‐enhanced uptake and disease‐modifying bioactivity of ingested extracellular vesiclesJournal of Extracellular Vesicles, 2021
- Exosomal LINC01005 derived from oxidized low‐density lipoprotein‐treated endothelial cells regulates vascular smooth muscle cell phenotypic switchBioFactors, 2020